ALS does not have a set lifespan—survival varies widely based on the type of ALS, age at diagnosis, and how quickly the disease progresses in your body

Most people diagnosed with ALS live between two and five years after diagnosis, but this is an average, not a rule. Some people live ten years or longer. Others progress much faster and die within a year. The variation is so wide that doctors cannot predict your individual timeline based on diagnosis alone. What matters more is how your specific disease behaves—whether it starts in your limbs or your breathing muscles, how old you are, and how your body responds to treatment.

The most common form, called limb-onset ALS, typically progresses more slowly than bulbar-onset ALS, which affects speech and swallowing first. People diagnosed after age 60 tend to have shorter survival times than those diagnosed in their 40s or 50s, though age alone does not determine outcome. Some younger people progress rapidly; some older people live well into their 70s or 80s with ALS.

Key Takeaways

  • Median survival is two to five years from diagnosis, but individual timelines range from months to over a decade.
  • Limb-onset ALS typically progresses slower than bulbar-onset ALS, which affects swallowing and speech first.
  • Age at diagnosis, disease progression speed, and respiratory function are the strongest predictors of survival length.
  • Riluzole and edaravone are medications that may slow progression, and respiratory support can extend life significantly.
  • Multidisciplinary care—involving neurology, respiratory therapy, nutrition, and palliative care—affects both survival and quality of life.

What the survival statistics actually measure

When doctors cite a two- to five-year median, they mean that half of people diagnosed live longer than that time and half live shorter. That number comes from large studies of people diagnosed over many years, but it does not tell you where you fall within that range. A median is useful for understanding the general picture; it is not useful for predicting your own course.

The statistics also depend on when they were collected. Studies from the 1990s showed shorter survival times than studies from the 2010s, partly because treatments have improved and partly because doctors are better at managing complications. If you read an article citing very old data, the numbers may not reflect current care.

How disease type and starting point affect how long people live

Limb-onset ALS begins with weakness in the arms or legs. People with this form tend to live longer—often five to ten years or more—because the breathing muscles are usually spared in the early stages. You have more time before respiratory support becomes necessary.

Bulbar-onset ALS starts with slurred speech or difficulty swallowing. This form progresses faster on average because swallowing problems can lead to aspiration, malnutrition, and respiratory complications more quickly. Median survival is often two to three years, though some people live much longer.

Primary lateral sclerosis (PLS) and progressive muscular atrophy (PMA) are rarer variants. PLS progresses very slowly—some people live 20 years or more—while PMA falls somewhere between typical ALS and PLS in speed.

Age and how fast the disease moves in your body

Age at diagnosis is one of the strongest predictors of survival. People diagnosed before age 50 have longer median survival—often five to ten years—than those diagnosed after 60, who may have median survival of two to three years. This is partly biological: younger bodies may tolerate the disease differently, and younger people often have fewer other health conditions that complicate ALS.

How quickly your disease progresses in the first months after diagnosis also predicts what comes next. If your strength declines rapidly in the first three to six months, progression tends to continue at that faster pace. If decline is slow early on, it often stays slower. This is why your neurologist will track your strength and function closely in the first year—the pattern you establish early gives real information about your likely course.

How respiratory function changes the timeline

The biggest factor in how long you live with ALS is what happens to your breathing muscles. ALS eventually weakens the diaphragm and intercostal muscles that control breathing. When those muscles fail, you face a choice: use respiratory support or not.

Non-invasive ventilation (NIV)—a mask connected to a machine that helps you breathe—can extend life by months to years. People who use NIV regularly, especially at night, often live significantly longer than those who do not. Some people use it only when sleeping; others use it during the day as well.

Invasive mechanical ventilation (a breathing tube placed in the windpipe) can extend life much further, sometimes by years. However, it requires 24-hour care, either at home or in a facility, and involves significant medical complexity. This is a major decision that involves your values, your support system, and your goals for care.

Respiratory decline is often the event that determines the end of life in ALS. Knowing your breathing status—measured by a test called forced vital capacity (FVC)—helps you and your doctors plan ahead.

Medications that may slow progression

Riluzole was the first medication shown to extend ALS survival. It may add a few months to life and slow progression slightly. It has been used since the 1990s and is well understood.

Edaravone is a newer medication that may slow decline in some people, particularly in the first months after diagnosis. It requires intravenous infusion and is not right for everyone, but some people see measurable slowing of weakness.

Neither medication stops ALS or reverses damage. Both work best when started early. Other medications in development may offer more benefit in the future, but as of now, these two are the main disease-modifying options available. Your neurologist can discuss whether either is appropriate for your situation.

How nutrition, infection prevention, and palliative care affect survival and quality of life

Swallowing problems develop in most people with ALS, especially those with bulbar-onset disease. Aspiration—food or liquid entering the lungs—causes pneumonia, which is a common cause of death in ALS. Working with a speech-language pathologist early, modifying food texture, and sometimes using a feeding tube (PEG tube) placed directly into the stomach can prevent aspiration and maintain nutrition. People who maintain good nutrition live longer and feel better.

Infections, particularly respiratory infections, accelerate decline. Simple measures like flu and pneumonia vaccines, hand hygiene, and avoiding sick people matter. Respiratory therapy and airway clearance techniques help prevent secretions from pooling in the lungs.

Palliative care—focused on comfort, symptom management, and planning—does not shorten life. It often improves it by managing pain, breathing difficulty, emotional distress, and other symptoms that make living with ALS harder. Starting palliative care early, alongside curative treatment, is standard in ALS care.

What you can control and what you cannot

You cannot control how fast your ALS progresses or which muscles it affects first. You can control whether you see a neurologist regularly, whether you take medications that may help, whether you work with a multidisciplinary ALS team (neurology, respiratory therapy, nutrition, social work, palliative care), and whether you plan ahead for respiratory support and end-of-life care.

People who receive coordinated, comprehensive care from an ALS center or clinic tend to live longer and report better quality of life than those who see only a general neurologist. This is not because the doctors are better; it is because the team catches problems early, manages symptoms proactively, and helps you make informed decisions about your care.

Frequently Asked Questions

Is ALS always fatal?

Yes. ALS is a progressive disease that eventually affects the muscles you need to breathe. Without respiratory support, death occurs when the breathing muscles fail. With respiratory support, life can be extended, but ALS itself is not reversible or curable at this time.

Can someone live 10 or 20 years with ALS?

Yes, though it is less common. People with slow-progressing limb-onset ALS, especially those diagnosed young, sometimes live 10 years or longer. Rarer variants like PLS can have much longer survival. However, most people live between two and five years.

Does using a breathing machine mean you will live longer?

Non-invasive ventilation (a mask) typically extends life by months to a few years. Invasive mechanical ventilation (a breathing tube) can extend life much longer, sometimes by years, but requires round-the-clock care. Whether to use either is a personal decision based on your values and circumstances.

What is the most common cause of death in ALS?

Respiratory failure—when the breathing muscles become too weak to work—is the most common cause. Aspiration pneumonia, caused by food or liquid entering the lungs due to swallowing problems, is also common. Infections and other complications can accelerate decline.

Does age at diagnosis always predict how long you will live?

Age is a strong predictor on average, but not for individuals. Some people diagnosed at 70 live longer than some diagnosed at 50. How fast your disease progresses in the first months is often a better predictor than age alone.